Literature DB >> 11916806

Spinal and peripheral mu opioids and the development of secondary tactile allodynia after thermal injury.

Natsuko Nozaki-Taguchi1, Tony L Yaksh.   

Abstract

UNLABELLED: Local thermal injury to the paw leads to an increased sensitivity to a noxious stimulus applied to the site (primary thermal hyperalgesia) and an increased sensitivity to tactile stimuli in skin sites adjacent to the primary injury (secondary tactile allodynia; 2 degrees TA). We sought to define the peripheral and spinal actions of mu opioids in regulating 2 degrees TA. First, a mild thermal injury was induced on one heel, producing 2 degrees TA. This 2 degrees TA was blocked by pretreatment, but not posttreatment, with a topical mu-opioid agonist, loperamide (1.7%-5%). Second, 2 degrees TA was blocked by intrathecal morphine (0.1-10 microg) pre- and postinjury. 2 degrees TA reappeared when systemic naloxone was given before, but not after, injury in intrathecal morphine-pretreated rats. Intrathecal remifentanil, a short-lasting mu-opioid agonist, infused periinjury (3 microg/min), did not block subsequent primary thermal hyperalgesia, but it produced a dose-dependent (0.3-3 microg/min) abolition of 2 degrees TA. Local tissue injury leads to 2 degrees TA by the activation of opiate-sensitive afferents and the initiation of a cascade that persists in the absence of that initiating injury-induced stimulus. IMPLICATIONS: Sensitivity to touch observed in areas adjacent to injury is blocked by opioids applied before, but not after, injury. This suggests that injury-activated opioid-sensitive fibers are responsible for sensitization and reveals a cascade that is diminished by pretreatment but not posttreatment, providing a rationale for adequate analgesia before injury (surgery) has occurred.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916806     DOI: 10.1097/00000539-200204000-00036

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Pain imaging in the emerging era of molecular medicine.

Authors:  Christian S Stohler; Jon-Kar Zubieta
Journal:  Methods Mol Biol       Date:  2010

2.  Analgesic properties of loperamide differ following systemic and local administration to rats after spinal nerve injury.

Authors:  C Chung; A F Carteret; A D McKelvy; M Ringkamp; F Yang; T V Hartke; X Dong; S N Raja; Y Guan
Journal:  Eur J Pain       Date:  2012-04-16       Impact factor: 3.931

3.  Secondary hyperalgesia in the rat first degree burn model is independent of spinal cyclooxygenase and nitric oxide synthase.

Authors:  Linda S Sorkin; Carmen M Doom; Karly P Maruyama; Danielle B Nanigian
Journal:  Eur J Pharmacol       Date:  2008-04-01       Impact factor: 4.432

Review 4.  Analgo-sedation of patients with burns outside the operating room.

Authors:  Cesare Gregoretti; Daniela Decaroli; Quirino Piacevoli; Alice Mistretta; Nicoletta Barzaghi; Nicola Luxardo; Irene Tosetti; Luisa Tedeschi; Laura Burbi; Paolo Navalesi; Fabio Azzeri
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection.

Authors:  Francesca Guida; Livio Luongo; Gabriella Aviello; Enza Palazzo; Maria De Chiaro; Luisa Gatta; Serena Boccella; Ida Marabese; Jordan K Zjawiony; Raffaele Capasso; Angelo A Izzo; Vito de Novellis; Sabatino Maione
Journal:  Mol Pain       Date:  2012-08-23       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.